Rifampin and pyrazinamide for treatment of latent tuberculosis infection - Is it safe?

被引：27

作者：

Jasmer, RM ^{[1
]}

Daley, CL ^{[1
]}

机构：

[1] Univ Calif San Francisco, San Francisco Gen Hosp, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA

来源：

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2003年 / 167卷 / 06期

关键词：

D O I：

10.1164/rccm.2301002

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

页码：809 / 810

页数：2

共 16 条

[11] Pyrazinamide and rifampin vs isoniazid for the treatment of latent tuberculosis - Improved completion rates but more hepatotoxicity [J].

McNeill, L ;

Allen, M ;

Estrada, C ;

Cook, P .

CHEST, 2003, 123 (01) :102-106

[12] Twice weekly tuberculosis preventive therapy in HIV infection in Zambia [J].

Mwinga, A ;

Hosp, M ;

Godfrey-Faussett, P ;

Quigley, M ;

Mwaba, P ;

Mugala, BN ;

Nyirenda, O ;

Luo, N ;

Pobee, J ;

Elliott, AM ;

McAdam, KPWJ ;

Porter, JDH .

AIDS, 1998, 12 (18) :2447-2457

[13] Hepatotoxicity associated with isoniazid preventive therapy - A 7-year survey from a public health tuberculosis clinic [J].

Nolan, CM ;

Goldberg, SV ;

Buskin, SE .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (11) :1014-1018

[14] Safety of 2 months of rifampin and pyrazinamide for treatment of latent tuberculosis [J].

Stout, JE ;

Engemann, JJ ;

Cheng, AC ;

Fortenberry, ER ;

Hamilton, CD .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 167 (06) :824-827

[15]

THOMPSON NJ, 1982, B WORLD HEALTH ORGAN, V60, P555

[16]

2001, AM J RESP CRIT CARE, V164, P1319

← 1 2 →